TELOSAF MT 40/25 TABLET

Product Description

Product Name: TELOSAF MT 40/25 TABLET
Composition: Telmisartan 40 mg + Metoprolol Succinate 25 mg (Sustained Release)

Product Description (SEO-Optimized for Trade India & B2B Platforms)

TELOSAF MT 40/25 TABLET is a clinically advanced antihypertensive combination, formulated with Telmisartan 40 mg (an angiotensin II receptor blocker) and Metoprolol Succinate 25 mg (a beta-blocker in sustained-release form). This dual-action therapy ensures comprehensive blood pressure control, reducing both systolic and diastolic pressure while offering cardioprotective benefits.

Manufactured by Agrosaf Pharmaceuticals in WHO-GMP certified facilities, this formulation is ideal for bulk purchasing, PCD pharma franchise, hospital tenders, and pharmacy distributors looking for reliable, high-demand cardiovascular medicines.

Key Benefits:

• Combines ARB and beta-blocker for synergistic hypertension management

• Sustained-release Metoprolol ensures steady, 24-hour action

• Helps prevent stroke, heart failure, and cardiovascular complications

• Convenient once-daily dosage promotes better patient adherence

Usage:

Indicated for the treatment of essential hypertension and cardiovascular risk reduction, particularly in patients requiring combination therapy.

Available for Bulk Orders, PCD Franchise & Contract Manufacturing.
Trust TELOSAF MT 40/25 TABLET for clinically effective and market-ready hypertension care.

TELOSAF MT Dual Power, Reliable Control.